The Full Wiki

More info on ACVRL1

ACVRL1: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

edit
Activin A receptor type II-like 1
Identifiers
Symbols ACVRL1; ACVRLK1; ALK-1; ALK1; HHT; HHT2; ORW2; SKR3; TSR-I
External IDs OMIM601284 MGI1338946 HomoloGene20058 GeneCards: ACVRL1 Gene
RNA expression pattern
PBB GE ACVRL1 210838 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 94 11482
Ensembl ENSG00000139567 ENSMUSG00000000530
UniProt P37023 Q91YR0
RefSeq (mRNA) NM_000020 NM_009612
RefSeq (protein) NP_000011 NP_033742
Location (UCSC) Chr 12:
50.59 - 50.6 Mb
Chr 15:
100.96 - 100.97 Mb
PubMed search [1] [2]

Serine/threonine-protein kinase receptor R3 is an enzyme that in humans is encoded by the ACVRL1 gene.[1][2][3]

ACVRL1 is a receptor in the TGF beta signaling pathway.

It is also known as "activin receptor-like kinase 1", or "ALK1".

This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2.[3]

Pathology

It is associated with hereditary hemorrhagic telangiectasia.

References

  1. ^ ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K (Oct 1993). "Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity". Oncogene 8 (10): 2879-87. PMID 8397373.  
  2. ^ Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA (Jul 1996). "Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2". Nat Genet 13 (2): 189-95. doi:10.1038/ng0696-189. PMID 8640225.  
  3. ^ a b "Entrez Gene: ACVRL1 activin A receptor type II-like 1". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=94.  

Further reading

  • Attisano L, Cárcamo J, Ventura F, et al. (1993). "Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.". Cell 75 (4): 671–80. doi:10.1016/0092-8674(93)90488-C. PMID 8242742.  
  • Johnson DW, Berg JN, Gallione CJ, et al. (1996). "A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.". Genome Res. 5 (1): 21–8. doi:10.1101/gr.5.1.21. PMID 8717052.  
  • Panchenko MP, Williams MC, Brody JS, Yu Q (1996). "Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels.". Am. J. Physiol. 270 (4 Pt 1): L547–58. PMID 8928814.  
  • Berg JN, Gallione CJ, Stenzel TT, et al. (1997). "The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.". Am. J. Hum. Genet. 61 (1): 60–7. doi:10.1086/513903. PMID 9245985.  
  • Stockwell BR, Schreiber SL (1998). "Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.". Curr. Biol. 8 (13): 761–70. doi:10.1016/S0960-9822(98)70299-4. PMID 9651680.  
  • Lux A, Attisano L, Marchuk DA (1999). "Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.". J. Biol. Chem. 274 (15): 9984–92. doi:10.1074/jbc.274.15.9984. PMID 10187774.  
  • Klaus DJ, Gallione CJ, Anthony K, et al. (2000). "Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online.". Hum. Mutat. 12 (2): 137. doi:10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU16>3.0.CO;2-J. PMID 10694922.  
  • Oh SP, Seki T, Goss KA, et al. (2000). "Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.". Proc. Natl. Acad. Sci. U.S.A. 97 (6): 2626–31. doi:10.1073/pnas.97.6.2626. PMID 10716993.  
  • Abdalla SA, Pece-Barbara N, Vera S, et al. (2000). "Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.". Hum. Mol. Genet. 9 (8): 1227–37. doi:10.1093/hmg/9.8.1227. PMID 10767348.  
  • Kjeldsen AD, Brusgaard K, Poulsen L, et al. (2001). "Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families.". Am. J. Med. Genet. 98 (4): 298–302. doi:10.1002/1096-8628(20010201)98:4<298::AID-AJMG1093>3.0.CO;2-K. PMID 11170071.  
  • Wurthner JU, Frank DB, Felici A, et al. (2001). "Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.". J. Biol. Chem. 276 (22): 19495–502. doi:10.1074/jbc.M006473200. PMID 11278302.  
  • Parks WT, Frank DB, Huff C, et al. (2001). "Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases.". J. Biol. Chem. 276 (22): 19332–9. doi:10.1074/jbc.M100606200. PMID 11279102.  
  • Birkey Reffey S, Wurthner JU, Parks WT, et al. (2001). "X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling.". J. Biol. Chem. 276 (28): 26542–9. doi:10.1074/jbc.M100331200. PMID 11356828.  
  • Trembath RC, Thomson JR, Machado RD, et al. (2001). "Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.". N. Engl. J. Med. 345 (5): 325–34. doi:10.1056/NEJM200108023450503. PMID 11484689.  
  • Inman GJ, Nicolás FJ, Callahan JF, et al. (2002). "SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.". Mol. Pharmacol. 62 (1): 65–74. doi:10.1124/mol.62.1.65. PMID 12065756.  
  • Olivieri C, Mira E, Delù G, et al. (2002). "Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia.". J. Med. Genet. 39 (7): E39. doi:10.1136/jmg.39.7.e39. PMID 12114496.  
  • Mo J, Fang SJ, Chen W, Blobe GC (2003). "Regulation of ALK-1 signaling by the nuclear receptor LXRbeta.". J. Biol. Chem. 277 (52): 50788–94. doi:10.1074/jbc.M210376200. PMID 12393874.  
  • Lamouille S, Mallet C, Feige JJ, Bailly S (2003). "Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis.". Blood 100 (13): 4495–501. doi:10.1182/blood.V100.13.4495. PMID 12453878.  

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message